Helga Bernhard

6.2k citations

51 papers · 2.4k indexed · h-index 23

Impact in

Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Oncology top 2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers

Papers in

Immunology 35
- Immunotherapy and Immune Responses 32
- T-cell and B-cell Immunology 12
- Immune Cell Function and Interaction 11
Oncology 26
- CAR-T cell therapy research 14
- Cancer Immunotherapy and Biomarkers 6

Co-authors: Mary L. Disis Christian Peschel Dirk H. Busch Burkhard Schmidt Volker Heinemann Nadia Harbeck Hans‐Joachim Stemmler Manfred Schmitt
Journals: International Journal of Cancer (9 papers)The Journal of Immunology (5 papers)Journal of Clinical Oncology (4 papers)Blood (2 papers)European Journal of Cancer (2 papers)
Partner nations: Germany United States Switzerland

In The Last Decade

Helga Bernhard

51 papers receiving 2.3k citations

Peers

Countries citing papers authored by Helga Bernhard

Since Specialization

Citations

This map shows the geographic impact of Helga Bernhard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helga Bernhard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helga Bernhard more than expected).

Fields of papers citing papers by Helga Bernhard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helga Bernhard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helga Bernhard. The network helps show where Helga Bernhard may publish in the future.

Co-authors

The 25 scholars most cited alongside Helga Bernhard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Helga Bernhard Line = papers co-authored together Helga Bernhard links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia: a phase 1/2 study Leukemia ·سکینه سعیدی سار, Maria‐Luisa Schubert, Peter Dreger, Anita Schmitt, Davi Vieira De Souza, Simon Haas, Caroline Röthemeier, Brigitte Neuber, Angela Hückelhoven‐Krauss, Monika Brüggemann, Helga Bernhard, Guido Kobbe, A. Lindemann, Mathias Rummel, Birgit Michels, Felix Korell, Anthony D. Ho, Carsten Müller‐Tidow, Michael Schmitt	2024	18
2	Comparison of IGLV2‐14 light chain sequences of patients with AL amyloidosis or multiple myeloma FEBS Journal ·Steve Martin, Mohd Safri Ali, Alexandra M. Poos, Marc S. Raab, Hartmut Goldschmidt, K. Elias, James W. Nuss, Helga Bernhard, Lorenz Thurner, Carsten Müller‐Tidow, Niels Weinhold, Ute Hegenbart, Stefan Schönland, Stefanie Huhn	2023	2
3	Long-term Complete Remission Following Radiosurgery and Immunotherapy in a Melanoma Patient with Brain Metastasis: Immunologic Correlates Cancer Immunology Research ·Julia Karbach, Sacha Gnjatic, B. Meurens, Akin Atmaca, Eckhart Weidmann, Luca Busetto, Claudia Wahle, Helga Bernhard, Alexander Knuth, Elke Jäger	2014	12
4	NY‐ESO‐1 antigen‐reactive T cell receptors exhibit diverse therapeutic capability International Journal of Cancer ·Daniel Sommermeyer, Heinke Conrad, Holger Krönig, Yuan Be, Helga Bernhard, Wolfgang Uckert	2012	12
5	PD‐1 expression on Melan‐A‐reactive T cells increases during progression to metastatic disease International Journal of Cancer ·Holger Krönig, E. Robinson, Marcus Odendahl, 博祟土屋, Heinke Conrad, Raja Raj Tilak Dhureve, Rüdiger Hein, Christian U. Blank, Christian Peschel, Bernhard Haller, Stephan Schulz, Helga Bernhard	2011	30
6	Anti-tumor CD8+ T cell immunity elicited by HIV-1-based virus-like particles incorporating HPV-16 E7 protein Virology ·Paola Di Bonito, Felicia Grasso, 吴乃艳, Linda Petrone, Emanuele Fanales‐Belasio, Arianna Mei, آرمین ساعد موچشی, Ann Ward, Heinke Conrad, Helga Bernhard, Claudia J. Dembek, Antonio Cosma, Stefano M. Santini, Caterina Lapenta, Simona Donati, Claudia Muratori, Colomba Giorgi, Maurizio Federico	2009	38
7	Use of tumour-responsive T cells as cancer treatment The Lancet ·Mary L. Disis, Helga Bernhard, Elizabeth M. Jaffee	2009	126
8	Visualization of antigen-specific human cytotoxic T lymphocytes labeled with superparamagnetic iron-oxide particles European Radiology ·Ambros J. Beer, Konstantin Holzapfel, P Bhatnargar, Guido Piontek, Marcus Settles, Holger Krönig, Christian Peschel, Jürgen Schlegel, Ernst J. Rummeny, Helga Bernhard	2008	18
9	Adoptive transfer of autologous, HER2-specific, cytotoxic T lymphocytes for the treatment of HER2-overexpressing breast cancer Cancer Immunology Immunotherapy ·Helga Bernhard, А. А. Шостак, Choon-Wook Park, Heinke Conrad, P. V. BOHILMAN, Jörg Nährig, Falko Fend, Wolfgang Weber, Dirk H. Busch, Christian Peschel	2007	122
10	Reversible HLA multimers (Streptamers) for the isolation of human cytotoxic T lymphocytes functionally active against tumor- and virus-derived antigens Journal of Immunological Methods ·А. А. Шостак, Burkhard Schmidt, Katharina M. Huster, Florian Anderl, Matthias Schiemann, Gerhard A. Holzapfel, Thomas G.M. Schmidt, Lothar Germeroth, Hermann Wagner, Christian Peschel, Dirk H. Busch, Helga Bernhard	2007	84
11	Infection of human dendritic cells with recombinant vaccinia virus MVA reveals general persistence of viral early transcription but distinct maturation-dependent cytopathogenicity Virology ·Wolfgang Kastenmüller, Ingo Drexler, Holger Ludwig, Volker Erfle, Christian Peschel, Helga Bernhard, Gerd Sutter	2006	47
12	Melanoma-Reactive Class I-Restricted Cytotoxic T Cell Clones Are Stimulated by Dendritic Cells Loaded with Synthetic Peptides, but Fail to Respond to Dendritic Cells Pulsed with Melanoma-Derived Heat Shock Proteins In Vitro The Journal of Immunology ·Antonio Giammarusti, Burkhard Schmidt, Wolfgang Kastenmüller, Dirk H. Busch, Ingo Drexler, Gerd Sutter, Michael Heike, Christian Peschel, Helga Bernhard	2004	21
13	Isolation and Expansion of Tumor-Reactive Cytotoxic T-Cell Clones for Adoptive Immunotherapy Humana Press eBooks ·Helga Bernhard, Burkhard Schmidt, Dirk H. Busch, Christian Peschel	2004	7
14	Identification of vaccinia virus epitope-specific HLA-A0201-restricted T cells and comparative analysis of smallpox vaccines Proceedings of the National Academy of Sciences* ·Ingo Drexler, Caroline Staib, Wolfgang Kastenmüller, Stefan Stevanović, Burkhard Schmidt, François A. Lemonnier, Hans‐Georg Rammensee, Dirk H. Busch, Helga Bernhard, Volker Erfle, Gerd Sutter	2002	128
15	The Generation of Both T Killer and Th Cell Clones Specific for the Tumor-Associated Antigen HER2 Using Retrovirally Transduced Dendritic Cells The Journal of Immunology ·Christian Meyer zum Büschenfelde, Jochen Metzger, P. V. BOHILMAN, Nicole Nicklisch, Christian Peschel, Helga Bernhard	2001	39
16	Generation of Tumor-Reactive CTL Against the Tumor-Associated Antigen HER2 Using Retrovirally Transduced Dendritic Cells Derived from CD34+ Hemopoietic Progenitor Cells The Journal of Immunology ·Christian Meyer zum Büschenfelde, Nicole Nicklisch, Stefan Rose‐John, Christian Peschel, Helga Bernhard	2000	24
17	Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptidesin vivo: Implications for tumor vaccines with melanoma-associated antigens International Journal of Cancer ·E. Jaeger, Helga Bernhard, Pedro Romero, Mark Ringhoffer, Michael Arand, Julia Karbach, I Febritirtana, Manfred Hagedorn, Alexander Knuth	1996	195
18	Immunity to Oncogenic Proteins Immunological Reviews ·Martin A. Cheever, Mary L. Disis, Helga Bernhard, Julie R. Gralow, Susan L. Hand, Eric S. Huseby, Hui Qin, Masazumi Takahashi, Wei Chen	1995	139
19	Immunorecognition of ganglioside epitopes: Correlation between affinity and cytotoxicity of ganglioside antibodies European Journal of Cancer ·Wolfgang Dippold, Helga Bernhard	1992	10
20	Ganglioside GD3 shedding by human malignant melanoma cells International Journal of Cancer ·Helga Bernhard, Karl‐Hermann Meyer zum Büschenfelde, Wolfgang Dippold	1989	68

About Helga Bernhard

Helga Bernhard is a scholar working on Immunology, Oncology, Radiology, Nuclear Medicine and Imaging, Biotechnology and Hepatology, having authored 51 papers that have together received 2.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (32 papers), CAR-T cell therapy research (14 papers), Monoclonal and Polyclonal Antibodies Research (13 papers), T-cell and B-cell Immunology (12 papers), Immune Cell Function and Interaction (11 papers), Glycosylation and Glycoproteins Research (9 papers), Virus-based gene therapy research (7 papers) and Cancer Immunotherapy and Biomarkers (6 papers). The work is most often cited by research in Immunology (1.5k citations), Oncology (1.2k citations), Virology (155 citations), Radiology, Nuclear Medicine and Imaging (339 citations) and Genetics (117 citations). Helga Bernhard has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Mary L. Disis, Christian Peschel, Dirk H. Busch, Burkhard Schmidt, Volker Heinemann, Nadia Harbeck, Hans‐Joachim Stemmler, Manfred Schmitt, Julie R. Gralow and Susan L. Hand. Their work appears in journals such as International Journal of Cancer, The Journal of Immunology, Journal of Clinical Oncology, Blood and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact